WeVote
Log In

Bill

Bill

S 4109

Stem Cell Therapeutic and Research Reauthorization Act of 2026

119th Congress Introduced by James Lankford and 2 co-sponsors

Reauthorizes federal stem cell research funding and updates clinical oversight regulations through 2030s to balance scientific advancement with ethical and safety standards.

Introduced in Senate
0
WeVote Research Nonpartisan
Bill Summary · S 4109

Legislative bill overview

S 4109 reauthorizes federal funding and oversight mechanisms for stem cell research and therapeutic development programs. The bill extends authorization for National Institutes of Health (NIH) stem cell initiatives and establishes updated regulatory frameworks for clinical applications of stem cell-derived treatments. It represents a continuation and modernization of existing stem cell research policy rather than a fundamental shift in direction.

Why is this important

Stem cell research has significant potential for treating degenerative diseases, spinal cord injuries, and certain cancers, but requires sustained federal funding and clear regulatory pathways to advance. The reauthorization ensures continuity of research programs while establishing guidelines that balance scientific innovation with ethical considerations and patient safety. This affects both the biomedical research community's ability to pursue treatments and the regulatory environment governing which therapies reach patients.

Potential points of contention

  • Embryonic stem cell research scope: Whether the bill maintains, expands, or restricts federal funding for research using embryonic stem cells, which remains ethically contested among members of Congress
  • Regulatory stringency vs. innovation speed: Disagreement over how much oversight is appropriate—more restrictions may slow therapeutic development while less oversight raises safety concerns
  • Funding allocation priorities: Competition over budget distribution between basic research, clinical trials, and specific disease focuses (neurodegenerative diseases vs. cancer vs. other applications)

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.